Outcome studies in schizophrenia

Irish Journal of Psychological Medicine

Volumn 16, Issue 4, 1999, Pages 140-144

  Browne, Stephen ^a   Larkin, Conall ^b   O'Callaghan, Eadbhard ^c  

^a WATERFORD REGIONAL HOSPITAL   (Ireland)

^b St John of God Hospitaller Services Ireland   (Ireland)

^c Cluain Mhuire Family Centre   (Ireland)

Author keywords

First episode; Methodological limitations; Outcome studies; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

DISEASE CLASSIFICATION; FOLLOW UP; HUMAN; LITERATURE; OUTCOMES RESEARCH; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 0032713068     PISSN: 07909667     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0790966700005528     Document Type: Review

References (85)

1. 1. Kraepelin E. Lehrbuch der Psychiatrie 4. Auflage. Abel Meixner: Leipzig, 1893.
2. 2. Bleuler E. Dementia praecox or the group of schizophrenias. (transl. J. Zinkin). International University Press, New York, 1950.
3. 3. Tsuang MT, Woolson RF, Fleming JA. Long-term outcome of major psychosis. Arch Gen Psych 1979; 36: 1295-301.
4. 4. McGlashan TH. The Chestnut Lodge follow-up study II. Long-term outcome of schizophrenia and the affective disorders. Arch Gen Psych 1984; 41: 585-601.
5. 5. Harding CM, Brooks GW, Asikaga T, Strauss T, Brier A. The Vermount longitudinal study of persons with severe mental illness. In: Methodology, study sample and overall status 32 years later. Am J Psych 1987; 144: 718-26.
6. 6. Bleuler M. The schizophrenic disorders: long-term patient and family studies (transl. Clemens SM). New Haven: Yale University Press, 1978.
7. 7. Huber G, Gross G, Schuttier R. Longitudinal studies of schizophrenic patients. Schiz Bull 1980; 6: 593-605.
8. 8. Prudo K, Blum HM. Five year outcome and prognosis in schizophrenia. Br J Psych 1987; 150: 345-54.
9. 9. Harrow M, Sands JR, Silverstein ML, Golberg JF. Course and outcome for schizophrenia versus other psychotic patients: a longitudinal study. Schiz Bull 1997; 23: 287-303.
10. 10. Zubin J, Magaziner J, Steinhauer SR. The metamorphosis of schizophrenia: from chronicity to vulnerability. Psychol Med 1983; 13: 551-71.
11. 11. Harrison G, Mason P. Schizophrenia - falling incidence and better outcome? Br J Psych 1993; 163: 535-41.
12. 12. Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen G. One hundred years of schizophrenia: A meta-analysis of the outcome literature. Am J Psych 1994; 151: 1409-16.
13. 13. Carone BJ, Harrow M, Westermeyer JF. Posthospital course and outcome in schizophrenia. Arch Gen Psych 1991; 48: 247-53.
14. 14. Breier A, Schreiber JL, Dyer J, Pickar D. National Institute of Mental Health longitudinal study of chronic schizophrenia. Arch Gen Psych 1991; 48: 239-46.
15. 15. McGlashan TH. Predictors of shorter, medium and longer term outcome in schizophrenia. Am J Psych 1986; 143: 50-5.
16. 16. Schwartz F, Terkelsen KG, Smith TE. Long-term outcome in chronic schizophrenia. Arch Gen Psych 1992; 49: 502.
17. 17. Green JH. Frequent rehospitalisation and non-compliance with treatment. Hosp Commun Psychiatry 1988; 39: 963-6.
18. 18. Sullivan G, Wells KB, Morgenstern H, Leake B. Identifying modifiable risk factors for rehospitalisation. Am J Psych 1995; 152: 1749-56.
19. 19. Mueser KT et al. Prevalence of substance abuse in schizophrenia: demographic and clinical factors. Schiz Bull 1990; 16: 31-56.
20. 20. Dixon L, Haas G, Weiden PJ, Sweeney I, Frances AJ. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psych 1991; 148: 224-30.
21. 21. Martinez-Arevalo MJ, Calcedo-Ordoniz A, Varo-Prieto JR. Cannabis consumption as a prognostic factor in schizophrenia. Br J Psych 1994; 164: 679-81.
22. 22. Ram R, Bromet EJ, Eaton W, Pato C, Schwartz JE. The natural course of schizophrenia: A review of first admission studies. Schiz Bull 1992; 18: 185-207.
23. 23. Strauss JS, Carpenter WT. Prediction of outcome in schizophrenia III. Five year outcome and its predictors. Arch Gen Psych 1977; 34: 159-63.
24. 24. Shepherd M, Watt D, Falloon I, Smeeton N. The natural history of schizophrenia: a five year follow-up study of outcome and prediction in a representative sample of schizophrenics. Psychol Med 1989; monograph suppl. 15.
25. 25. Wing JK. Five year outcome in early schizophrenia. Proc Royal Soc Med 1966; 59: 17-8.
26. 26. Stephens JH. Long-term prognosis and follow-up in schizophrenia. Schiz Bull 1978; 4: 25-47.
27. 27. Ciompi L. Catamnestic long-term study on the course of life and ageing of schizophrenics. Schiz Bull 1980; 6: 606-18.
28. 28. Wyatt RJ. Neuroleptics and the natural course of schizophrenia. Schiz Bull 1991; 17: 325-51.
29. 29. Mojtabai R, Nicholson RA, Carpenter BN. Role of psychosocial treatments in management of schizophrenia: A meta-analytic review of controlled outcome studies. Schiz Bull 1998; 24: 569-87.
30. 30. Strauss JS, Carpenter WT. The prediction of outcome in schizophrenia II. Relationships between predictor and outcome variables. Arch Gen Psych 1974; 31: 37-42.
31. 31. Carpenter WT, Strauss JS. The prediction of outcome in schizophrenia IV: 11 year follow-up of the IPSS cohort. J Nerv Ment Dis 1991; 179: 517-25.
32. 32. Harrow M, Carone BI, Westermeyer JF. Subjective conclusions about schizophrenia. Arch Gen Psych 1992; 49: 75
33. 33. Achte KA. On prognosis and rehabilitation in schizophrenia and paranoid psychoses: A comparative study of two series of patients first admitted to hospital in 1950 and 1960 respectively. Acta Psychiatr Scand 1967; 43: 5-125.
34. 34. Postrado LT, Lehman AF. Quality of life and clinical predictors of rehospitalisation of persons with severe mental illness. Psychiatr Serv 1995; 46: 1161-5.
35. 35. Ni Nuallain M, O'Hare A, Walsh D. Incidence of schizophrenia in Ireland. Psychol Med 1987; 17: 743-8.
36. 36. Aberg-Wistedt A, Cressell T, Lidberg Y, Liljenberg B, Osby U. Two-year outcome of team-based intensive case management for patients with schizophrenia. Psychiatr Serv 1995; 46: 1263-6.
37. 37. Collins EJ, Hogan TP, Desai H. Measurement of therapeutic response in schizophrenia. Schiz Res 1991; 5: 249-53.
38. 38. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia. Am J Psych 1996; 153: 321-30.
39. 39. Norman R et al. Symptoms and cognition as predictors of community functioning: A prospective analysis. Am J Psych 1999; 156: 400-5.
40. 40. Browne S et al. Quality of life in schizophrenia: its relationship to symptomatology, sociodemographic factors and tardive dyskinesia. Acta Psych Scand 1996; 94: 118-24.
41. 41. Browne S, Garavan J, Roe M, Gervin M, Larkin C, O'Callaghan E. Quality of life in schizophrenia; insight and subjective response to neuroleptics. J Nerv Ment Dis 1998; 186: 74-8.
42. 42. Van Putten T. Why do schizophrenic patients refuse to take their drugs?. Arch Gen Psych 1974; 31: 67-72.
43. 43. Hogan TP, Awad AG. Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures. Psychol Med 1992; 22: 347-52.
44. 44. Kemp R, Dvid A. Psychological predictors of insight and compliance in psychotic patients. Br J Psych 1996; 169: 444-50.
45. 45. Garavan J et al. Compliance with neuroleptic medication in outpatients with schizophrenia; its relationship to insight, subjective response to neuroleptics and attitudes to medication. Comp Psych 1998; 39: 215-8.
46. 46. Meltzer HY. Dimensions of outcome with clozapine. Br J Psych 1992; 160 (suppl. 17): 46-53.
47. 47. Van Os J, Wright P, Murray RM. Follow-up studies of schizophrenia I: natural history and non-psychopathological predictors of outcome. Eur Psych 1997; 12 (suppl. 5): 327s-341s.
48. 48. Report of Working Group on Outcome Indicators for Severe mental Illness. HMSO, London, 1999.
49. 49. Lieberman JA, Matthews S, Kirch DG. First episode psychosis. Schiz Bull 1992; 18: 349-50.
50. 50. Mason P, Harrison G, Glazebrook C, Medley I, Croudace T. The course of schizophrenia over 13 years. Br J Psych 1996; 169: 580-6.
51. 51. Westermeyer JF, Harrow M, Marengo JT. Risk of suicide in schizophrenia and other psychotic and non psychotic disorders. J Nerv Ment Dis 1991; 179: 259-66.
52. 52. Robinson DG et al. Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Am J Psych 1999; 156: 544-9.
53. 53. Sheitman BB, Lee H, Strauss R, Lieberman JA. The evaluation and treatment of first-episode psychosis. Schiz Bull 1997; 23: 653-61.
54. 54. Remington G, Kapur S, Zipursky RB. Pharmacotherapy of first episode schizophrenia. Br J Psych 1998; 172 (suppl 33): 66-70.
55. 55. Kane JM. Schizophrenia. N Eng J Med 1996; 334: 34-9.
56. 56. Kopala LC, Spontaneous and drug induced movement disorders in schizophrenia. Acta Psychiatr Scand 1996; 389: 12-7.
57. 57. Lieberman J et al. Time course and biological correlates of treatment response in first-episode schizophrenia. Arch Gen Psych 1993; 50: 369-76.
58. 58. Szymanski S, Cannon T, Gallacher F, Erwin RI, Gur RE. Course of treatment response in first episode and chronic schizophrenia. Am J Psych 1996; 153: 519-25.
59. 59. Saykin AI et al. Neuropsychological deficits in neuroleptic naive patients with first episode schizophrenia. Arch Gen Psych 1994; 51: 124-31.
60. 60. Hoff AL, Riordan H, O' Donnell DW, Morris L, De Lisi LE. Neuropsychological functioning of first episode schizophreniform patients. Am J Psych 1992; 149: 898-902.
61. 61. Barnes TRE. Commentary, Response to Professor Kirwan. Psychiatr Bull 1996; 20: 26-9.
62. 62. Sharma T. Cognitive effects of conventional and atypical antipsychotics in schizophrenia. Br J Psych 1999; 174 (suppl 38): 44-51.
63. 63. Zipursky RB, Zhang Wong J, Lambe EK, Bean G, Beiser M. MRI correlates of treatment response in first episode psychosis. Schiz Res 1997; 30: 81-90.
64. 64. Johnstone BC, MacMillan F, Frith CD, Benn DK, Crow TJ. Further investigation of the predictors of outcome following first episode schizophrenic episodes. Br J Psych 1990; 157: 182-9.
65. 65. Birchwood M, Mc Gorry P, Jackson H. Early intervention in schizophrenia. Br J Psych 1997; 170: 2-5.
66. 66. Beiser M, Erickson D, Fleming JA, Iacono WG. Establishing the onset of psychotic illness. Am J Psych 1993; 150: 1349-54.
67. 67. Humphreys MS, Johnstone BC, MacMillan IF, Taylor PJ. Dangerous behaviour preceding first admissions for schizophrenia. Br J Psych 1992; 161: 501-5.
68. 68. Crow TJ, MacMillan JF, Johnson AL, Johnstone BC. A randomised controlled trial of prophylactic neuroleptic treatment. Br J Psych 1986; 448: 120-27.
69. 69. Loebel AD, Lieberman JA, Alvir JM, Mayerhoff D, Geisler SH, Szymanski S. Duration of psychosis and outcome in first episode schizophrenia. Am J Psych 1992; 149: 1183-8.
70. 70. Haas GL, Garratt LS, Sweeney JA. Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness. J Psychiatr Res 1998; 32: 151-9.
71. 71. McGorry PD, Edwards J, Mihalopoulos C, Harrigan SM, Jackson HJ. EPPIC: An evolving system of early detection and optimal treatment. Schiz Bull 1996; 22: 305-25.
72. 72. Harrison G, Croudace T, Mason P, Glazebrook C, Medley I. Predicting the long-term outcome of schizophrenia. Psychol Med 1996; 26: 697-705.
73. 73. McGlashan TH, Johannessen JO. Early detection and intervention with schizophrenia: rationale. Schiz Bull 1996; 22: 201-22.
74. 74. Larsen TK, McGlashan TH, Moe LC. First episode schizophrenia: early course parameters. Schiz Bull 1996; 22: 241-56.
75. 75. Verdoux H et al. Prediction of duration of psychosis before first admission. Eur Psych 1998; 13: 346-52.
76. 76. Birchwood M, Cochrane R, MacMillan F, Copestake S, Kucharska J, Cariss M. The influence of ethnicity and family structure on relapse in first episode schizophrenia. Br J Psych 1992; 161: 783-90.
77. 77. The Scottish Schizophrenia Research Group. The Sottish First Episode Schizophrenia Study V. One-year follow up. Br J Psych 1988; 152: 470-6.
78. 78. Robinson D et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psych 1999; 56: 241-7.
79. 79. Hambrecht M, Hafner H. Substance abuse and the onset of schizophrenia. Biol Psych 1996; 40: 1155-63.
80. 80. Cantwell R et al. Prevalence of substance misuse in first episode psychosis. Br J Psych 1999; 174: 150-3.
81. 81. Kovasznay B, Fleischer J, Tanenberg-Karant M, Jandorf L, Miller A, Bromet E. Substance use disorder and the early course of illness in schizophrenia and affective psychosis. Schiz Bull 1997; 23: 195-201.
82. 82. Addington J, Addington D. Effect of substance misuse in early psychosis. Br J Psych 1998; 172 (suppl 33): 134-6.
83. 83. Jackson H, et al. Cognitively orientated psychotherapy for early psychosis (COPE). Br J Psych 1998; 172 (suppl 33): 93-100.
84. 84. Haddock G, Morrison AP, Hopkins R, Lewis S, Tarrier N. Individual cognitive behavioural interventions in early psychosis. Br J Psych 1998; 172 (suppl 33): 101-6.
85. 85. Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent onset schizophrenic disorders. Arch Gen Psych 1994; 51: 273-9.